Fig. 6From: Comparison of a teratogenic transcriptome-based predictive test based on human embryonic versus inducible pluripotent stem cellsComparison of the common developmental genes observed at day 14 in all three cell lines in the absence of valproic acid (VPA) with the VPA-deregulated genes at day 14 in each cell line (absolute fold change > 2, false discovery rate-corrected p value < 0.05). a Overlap of the developmental upregulated genes with the VPA-induced downregulated genes (four genes; see C for fold changes). b Overlap of developmental downregulated genes with the VPA-induced upregulated genes (11 genes; see D and E for fold changes). c Fold change values for B3GALNT1, 233944_at, DOK6, and BCL2 for all three cell lines. d Fold change values for C9orf135, GPR176, LRAT, NFE2L3, MICB, HSPA2, and CLDN10 for all three cell lines. e Fold change values for PFKP, PRKCB, CD9 and OGDHL for all three cell linesBack to article page